Skip to main content
. 2021 Jun 21;14:2695–2702. doi: 10.2147/IJGM.S314904

Table 1.

Baseline Characteristic of the Study Participants with Chronic Kidney Disease (n=2142)

Characteristics Quintile Categories of Serum Folate, ng/mL p-values
Q1 (<8.7) Q2 (8.7–11.4) Q3 (11.5–14.6) Q4 (14.7–19.1) Q5 (≥19.2)
N 422 431 428 427 434
Age (yr) 45.42 (18.32) 44.22 (18.03) 48.54 (18.90) 51.03 (19.48) 59.73 (20.38) <0.001
BMI (Kg/m2) 29.07 (6.59) 28.86 (7.05) 27.96 (5.93) 27.40 (5.40) 27.17 (5.45) <0.001
eGFR (mL/min/1.73 m2) 46.87 (9.80) 47.20 (9.73) 44.94 (10.66) 44.42 (10.66) 42.51 (10.13) <0.001
Urinary albumin (ug/mL) 9.00 (0.40–4870.00) 8.40 (0.40–9910.00) 8.40 (0.20–9820.00) 7.60 (0.30–3580.00) 8.40 (0.20–7570.00) 0.064
Urinary creatinine (g/L) 1.28 (0.12–4.59) 1.24 (0.09–5.34) 1.15 (0.09–7.74) 1.05 (0.07–5.48) 0.86 (0.06–3.98) <0.001
Time to death or censorship from time of examination (months) 56.12 (11.84) 58.28 (9.40) 57.76 (9.67) 58.60 (8.79) 56.24 (12.21) <0.001
Folate as dietary folate equivalents (mcg) 410.00 (0.00–2781.00) 423.00 (0.00–5715.00) 454.00 (66.00–2388.00) 477.00 (66.00–6635.00) 494.00 (38.00–3126.00) <0.001
Food folate (mcg) 157.50 (0.00–1557.00) 178.00 (0.00–1209.00) 184.00 (23.00–702.00) 188.00 (16.00–1242.00) 189.50 (12.00–1227.00) <0.001
Hemoglobin A1c (%) 5.61 (1.01) 5.65 (1.21) 5.61 (1.11) 5.58 (1.05) 5.60 (1.06) 0.895
Serum Vitamin B12 (pg/mL) 412.00 (100.00–9442.00) 423.00 (94.00–52710.00) 454.00 (80.00–16114.00) 475.00 (94.00–2710.00) 575.50 (100.00–3076.00) <0.001
Albumin (g/dL) 4.13 (0.35) 4.18 (0.33) 4.24 (0.29) 4.18 (0.33) 4.14 (0.38) <0.001
Serum glucose (mg/dL) 98.76 (37.64) 98.10 (38.70) 96.60 (33.37) 95.75 (31.93) 98.46 (34.23) 0.680
Phosphorus (mg/dL) 3.73 (0.55) 3.69 (0.53) 3.72 (0.52) 3.76 (0.57) 3.82 (0.57) 0.006
Uric acid (mg/dL) 5.17 (1.48) 5.19 (1.54) 5.20 (1.40) 5.14 (1.47) 5.33 (1.62) 0.383
TIBC, Frozen serum (ug/dL) 371.44 (72.17) 367.11 (63.66) 374.23 (64.47) 376.02 (65.96) 368.16 (75.14) 0.254
Mortality <0.001
Alive 387 (91.71%) 408 (94.66%) 401 (93.69%) 410 (96.02%) 379 (87.33%)
Death 35 (8.29%) 23 (5.34%) 27 (6.31%) 17 (3.98%) 55 (12.67%)
Sex 0.004
Female 250 (59.24%) 259 (60.09%) 260 (60.75%) 282 (66.04%) 303 (69.82%)
Male 172 (40.76%) 172 (39.91%) 168 (39.25%) 145 (33.96%) 131 (30.18%)
Hypertension <0.001
No 285 (67.54%) 320 (74.25%) 302 (70.56%) 308 (72.13%) 232 (53.46%)
Yes 129 (30.57%) 109 (25.29%) 124 (28.97%) 119 (27.87%) 201 (46.31%)
No records 8 (1.90%) 2 (0.46%) 2 (0.47%) 0 (0.00%) 1 (0.23%)
Physical activity 0.005
Sit during the day 138 (32.70%) 123 (28.54%) 118 (27.57%) 92 (21.55%) 110 (25.35%)
Stand/Walk a lot 111 (26.30%) 117 (27.15%) 107 (25.00%) 87 (20.37%) 113 (26.04%)
Light load/Climb stairs often 54 (12.80%) 66 (15.31%) 60 (14.02%) 76 (17.80%) 70 (16.13%)
Heavy work/load 97 (22.99%) 103 (23.90%) 112 (26.17%) 144 (33.72%) 119 (27.42%)
No records 22 (5.21%) 22 (5.10%) 31 (7.24%) 28 (6.56%) 22 (5.07%)
Race <0.001
Black 114 (27.01%) 108 (25.06%) 73 (17.06%) 61 (14.29%) 40 (9.22%)
Mexican American 106 (25.12%) 104 (24.13%) 101 (23.60%) 97 (22.72%) 48 (11.06%)
Other Hispanic 12 (2.84%) 23 (5.34%) 22 (5.14%) 21 (4.92%) 14 (3.23%)
Other ethnicity 190 (45.02%) 196 (45.48%) 232 (54.21%) 248 (58.08%) 332 (76.50%)
Chronic kidney disease 0.002
Stage2 10 (2.37%) 14 (3.25%) 3 (0.70%) 3 (0.70%) 1 (0.23%)
Stage3 386 (91.47%) 397 (92.11%) 392 (91.59%) 389 (91.10%) 398 (91.71%)
Stage4 23 (5.45%) 18 (4.18%) 26 (6.07%) 25 (5.85%) 25 (5.76%)
Stage5 3 (0.71%) 2 (0.46%) 7 (1.64%) 10 (2.34%) 10 (2.30%)

Notes: Values are presented as mean (standard deviation) or median (minimum-maximal) for continuous variables, and as number (percentage) for categorical variables.

Abbreviations: BMI, body mass index; eGFR, estimated glomerular filtration rate; TIBC, total iron binding capacity.